Postgrad LIVE! Study Fairs

Birmingham | Edinburgh | Liverpool | Sheffield | Southampton | Bristol

Wellcome Trust Featured PhD Programmes
Engineering and Physical Sciences Research Council Featured PhD Programmes
University of Oxford Featured PhD Programmes
Birkbeck, University of London Featured PhD Programmes
University of Manchester Featured PhD Programmes
"induced" AND "pluripoten…×
10 miles

induced pluripotent stem cells PhD Projects, Programs & Scholarships

We have 31 induced pluripotent stem cells PhD Projects, Programs & Scholarships

  • "induced" AND "pluripotent" AND "stem" AND "cells" ×
  • clear all
Order by 
Showing 1 to 10 of 31
  Modelling brain development using human induced pluripotent stem cells
  Dr E Becker
Application Deadline: 11 January 2019
The human brain is arguably the most complex structure among living organisms. Its development from single cells into a highly elaborate and unique organ has intrigued scientists for generations, yet remains incompletely understood.
  Influence of underlying matrix on induced pluripotent stem cell differentiation and integration of trabecular meshwork cells
  Dr CM Sheridan, Dr R Oldershaw
Applications accepted all year round
There is an urgent need for further treatment options for the blinding condition of Glaucoma Unfortunately with age there is a progressive loss of cells (Trabecular meshwork) from the eye’s outflow pathway which is even more severe with patients with glaucoma.
  Bioengineering stem cells for neuroprotection against stroke
  Dr N Vasudevan, Dr E Delivopoulos, Prof S Nasuto
Applications accepted all year round
"Stroke, in particular ischaemic stroke, is the third major cause of death worldwide and there is significant health impairment in survivors.
  Regulation of autophagy in human embryonic stem cells and its therapeutic application in induced pluripotent stem cell-based disease models
  Dr S Sarkar
Applications accepted all year round
Project background. Regulation of proteostasis is critical for maintaining tissue homeostasis. Autophagy, a major intracellular degradation pathway essential for cellular and energy homeostasis, functions in the clearance of aggregation-prone proteins and damaged organelles.
  Development of transducers or “brain-on-a-chip” platforms to record and modulate brain cells.
  Dr P Rocha
Application Deadline: 30 April 2019
The Bioelectronics group at the University of Bath in UK has a project focusing on the development of transducers or “brain-on-a-chip” platforms to record and modulate brain cells.
  Signalling pathways maintaining human embryonic stem cells
  Prof S J Kimber, Prof D Brison
Applications accepted all year round
The aim of this project is to determine the function of novel genes predicted to have critical roles in preimplantation human development and in disease in later life.
  Understanding Neuroinflammation through advanced in vitro 3D modelling using human Pluripotent Stem Cells
  Dr S Cowley, Prof W S James
Application Deadline: 25 January 2019
Microglia - brain-resident macrophages - carry out homeostatic surveillance functions in the brain, clearing dying cells, extracellular debris, and pruning synapses during development.
  Modulatory functions of microglia on medium spiny neuron function and degeneration in stem cell models of Huntington’ Disease
  Prof N Allen, Prof A Rosser
Application Deadline: 15 December 2018
Studentship Summary. This studentship is part of a SCTN-Training network of 14 studentships, funded by the European Union Horizon 2020 Programme (H2020-MSCA-ITN-2018) under the Marie Skłodowska-Curie Initial Training Network and Grant Agreement No.
  Investigating inflammasome regulation in human myeloid cells
  Research Group: Centre for Experimental Medicine
  Dr R Coll, Prof P Moynagh
Application Deadline: 20 January 2019
Inflammasomes are protein complexes that control inflammation in both infection and sterile injury. Aberrant inflammasome activation is a driver of many diseases including.
  Targeting TFEB to correct autophagy/lysosomal deficits in Parkinson’s disease
  Prof R Wade-Martins
Application Deadline: 11 January 2019
Commercial partner. Biogen, Cambridge, Massachusetts, USA. Parkinson’s disease is the second most common neurodegenerative disorder but disease-modifying therapies are still lacking.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2018
All rights reserved.